“HIGH-DOSE-RATE AND LOW-DOSE-RATE BRACHYTHERAPY AS MONOTHERAPY FOR CLINICALLY LOCALIZED PROSTATE CANCER” (2019) Voprosy onkologii, 65(3), pp. 434–440. doi:10.37469/0507-3758-2019-65-3-434-440.